A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintenance for Non-Squamous NSCLC in Sweden
Bryden, P.A, Kumar, G, Winfree, K.B, Boye, M.E, Taipale, K, Thompson, R, Borgeke, H
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
A Cost-Effectiveness Analysis of First Line Induction and Maintenance Treatment Sequences in Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in the United States
Kumar, G, Woods, B, Winfree, K.B, Boye, M.E, Hess, L.M, Bryden, P.A, Koustenis, A, Treat, J
Published in Value in health (01.05.2014)
Published in Value in health (01.05.2014)
Get full text
Journal Article
PUK17 Economic Benefits of Slowing Progress to End Stage Renal Disease (ESRD) in Patients with Diabetes-Related Chronic Kidney Disease (DKD), Compared with Standard of Care (SOC)
Smolen, L.J, Klein, T.M, Voelker, J.R, Sierra-johnson, J, Boye, M.E
Published in Value in health (01.06.2012)
Published in Value in health (01.06.2012)
Get full text
Journal Article
Direct medical costs for complications among adults with type 2 diabetes in a us commercial payer setting
Yeaw, J, Halinan, S, Hines, D, DeLozier, A.M, Perez, M, Boye, M.E, Boye, K.S, Blanchette, C
Published in Value in health (01.05.2013)
Published in Value in health (01.05.2013)
Get full text
Journal Article
PCN148 Review of National Institute for Health and Clinical Excellence (NICE) Recommendations for Anti-Cancer Agents Across Multiple Drug-Indication Combinations
Chawla, A, Oza, A, Nellesen, D, Brown, J, Liepa, A.M, Price, G, Nash-Smyth, E, Cuyun Carter, G, Boye, M.E
Published in Value in health (01.11.2012)
Published in Value in health (01.11.2012)
Get full text
Journal Article
PCN85 - A Cost-Effectiveness Analysis of First Line Induction and Maintenance Treatment Sequences in Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in the United States
Kumar, G., Woods, B., Winfree, K.B., Boye, M.E., Hess, L.M., Bryden, P.A., Koustenis, A., Treat, J.
Published in Value in health (01.05.2014)
Published in Value in health (01.05.2014)
Get full text
Journal Article
PCN101 - A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintenance for Non-Squamous NSCLC in Sweden
Bryden, P.A., Kumar, G., Winfree, K.B., Boye, M.E., Taipale, K., Thompson, R., Borgeke, H.
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)
Obasaju, C., Bowman, L., Wang, P., Shen, W., Winfree, K.B., Smyth, E.N., Boye, M.E., John, W., Brodowicz, T., Belani, C.P.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
PHS30 - Direct medical costs for complications among adults with type 2 diabetes in a us commercial payer setting
Yeaw, J., Halinan, S., Hines, D., DeLozier, A.M., Perez, M., Boye, M.E., Boye, K.S., Blanchette, C.
Published in Value in health (01.05.2013)
Published in Value in health (01.05.2013)
Get full text
Journal Article